dr. birrer on parp inhibitors in ovarian cancer
Published 6 years ago • 165 plays • Length 1:49Download video MP4
Download video MP3
Similar videos
-
1:56
dr. birrer on parp inhibitors in ovarian cancer
-
2:30
dr. birrer on parp inhibitors in ovarian cancer
-
0:51
michael j. birrer, md, phd, considers the benefits of various parp inhibitors in ovarian cancer
-
1:15
dr. birrer on fda approval of rucaparib in ovarian cancer
-
8:44
parp inhibition in ovarian cancer
-
1:11
dr. berek discusses the impact of parp inhibitors on ovarian cancer
-
2:34
dr. birrer on other targets in ovarian cancer
-
1:58
dr. birrer on the approval process in ovarian cancer
-
6:20
parp inhibitors in recurrent ovarian cancer
-
6:35
asco 2018: dr. birrer on practice-changing ovarian cancer studies
-
2:41
michael birrer, md, on the key takeaways from the ovarian plenary session in ovarian cancer
-
3:06
recurrent ovarian cancer: choosing a parp inhibitor
-
0:56
dr. backes on quality of life with parp inhibitors in ovarian cancer
-
1:34
dr. birrer discusses recurrent ovarian cancer treatment
-
0:48
dr. crane on the impact of parp inhibitors in ovarian cancer
-
1:08
dr. essel on repeat use of parp inhibitors in ovarian cancer
-
1:50
dr. birrer on the ovarian cancer avastin os benefit
-
0:53
dr. mirza on the impact of parp inhibitors in ovarian cancer
-
1:15
dr. konner on parp inhibitors in ovarian cancer